Press release
Cancer Molecular Biomarkers Market Estimated to Expand at a Robust CAGR over 2021
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/3841
Genetic methods include DNA arrays, southern blot, polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), and reverse transcriptase polymerase chain reaction (RT-PCR). Protein methods include immunohistochemistry (IHC) and mass spectrometry (MS). Imaging methods include positron emission tomography (PET), computed tomography (CT), magnetic resonance spectroscopy (MRS), x-ray, ultrasound, magnetic resonance imaging (MRI), and biophotonics.
North America has the largest market for cancer molecular biomarkers due to the growing IT industry, technological advancements, rise in the incidences of cancer, growing spending from government and private healthcare organizations, and improved healthcare infrastructure in this region.The North America market for cancer molecular biomarkers is followed by Europe. Asia is expected to witness high growth rate in thecancer molecular biomarkers market in the next few years due toincreasing research and development activities, rise in government intervention, growing awareness regarding cancer molecular biomarkers, and improving healthcare infrastructurein the region.
Factors such as technological advancements, increasing research and development activities, increase in funding from various government and non-government organizations, rise in healthcare expenditure, non invasive technology, increasing incidences of cancer, and streamlined drug delivery process are expected to drive the market for cancer molecular biomarkers .In addition, growing survival rates and increased accuracy of diagnosis with the help of biomarkers are expected to drive market for cancer molecular biomarkers.
However, issues related to reimbursement, high cost of diagnosis, requirement of immediate processing , lack of awareness, and various validation issues aresome of the major factors restraining growth of the globalcancer molecular biomarkers market.
Growing populationand economies in developing countries such as India and China is expected to drive growth of thecancer molecular biomarkers market in Asia. In addition,despite high cost involved in R&D, pharmaceutical companies are showing increased interest in this field and innovations along with technological advancement such as emergence of genetic based in vitro diagnostics, enhanced therapeutic effectiveness and decrease in the severity of the adverse effects are expected to offer new opportunities for global cancer molecular biomarkers market . Increasing number of mergers and acquisitions, risingnumber of collaborations, and product launches are some of the latest trends in the global cancer molecular biomarkers market.
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/3841
Some of the major companies operating in the global cancer molecular biomarkers market are Correlogic Systems, Inc., AgendiaBv, bioMerieux S.A, Aureon Laboratories, Inc., Astellas Pharma US, Inc., and Becton. In addition, other companies operating in the global cancer molecular biomarkers market include Diadexus, Inc., Abbott Laboratories, Affymetrix, Inc., Clarient, Inc., Biomoda, Inc., Beckman Coulter, Inc., and Dickinson and Company.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Molecular Biomarkers Market Estimated to Expand at a Robust CAGR over 2021 here
News-ID: 933053 • Views: …
More Releases from Persistence Market Research
Packaging Machinery Market to Surpass US$ 82.3 Bn by 2030 with Steady 4.7% CAGR …
➤Overview of the Market
According to the latest analysis by Persistence Market Research, the global packaging machinery market is projected to grow from US$ 59,737.4 million in 2023 to US$ 82,389.7 million by 2030, registering a CAGR of 4.7% during the forecast period. Rising consumer demand for packaged goods, automation, and technological upgrades in manufacturing are among the key forces transforming the industry landscape.
The packaging machinery market plays a vital role…
Packaging Tensioner Market Set to Reach US$ 13.3 Bn by 2030 with 3.8% CAGR - Per …
➤ Overview of the Market
According to Persistence Market Research, the global packaging tensioner market is projected to rise from US$ 10,237.5 million in 2023 to US$ 13,291.5 million by 2030, expanding at a CAGR of 3.8%. Packaging tensioners, essential for securing strapping around pallets, cartons, and bundled goods, are increasingly adopted across industries to ensure safe and efficient handling during transport. Growth is primarily driven by automation trends in packaging,…
Beverage Packaging Market to Surpass US$ 138.9 Bn by 2031 Driven by Sustainabili …
➤Overview of the Market
According to the latest study by Persistence Market Research, the global beverage packaging market is projected to grow at a CAGR of 4.1% from US$ 1,04,820.0 million in 2024 to US$ 1,38,867.1 million by 2031. Rising consumer preference for sustainable packaging, growing consumption of ready-to-drink products, and ongoing innovation in material science are major factors boosting the industry worldwide.
The beverage packaging industry plays a vital role in…
Actuators Device Market to Reach US$ 102.8 Bn by 2031 Fueled by 7% CAGR and Auto …
➤ Overview of the Market
The global actuators device market is poised for robust growth, projected to rise from US$ 67.7 Bn in 2024 to US$ 102.8 Bn by 2031 at a CAGR of 7%, according to Persistence Market Research. Rapid automation across industries, growing investment in industrial robotics, and expanding applications in aerospace, automotive, and medical devices are key catalysts for market acceleration.
The actuators device market encompasses mechanical systems that…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
